A Randomized, placebo controlled, double-blind, parallel-group, multicentre PhaseIII dose finding Study of M516102 in the treatment of pruritus associated with atopic dermatitis, Protocol No: M516102-EU03
Laufzeit: 01.01.2008 - 31.12.2010
imported
Kurzfassung
Protocol No: M516102-EU03
